Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Retaane safe in patients with macular degeneration

March 14, 2005

RNAi therapeutic shows potential for AMD in animal model

March 8, 2005

Positive preliminary phase II data for Evizon in AMD

March 8, 2005

OccuLogix cleared to begin crossover studies of RHEO system for dry AMD

March 3, 2005

First patient treated in phase I advanced AMD study of Litx

March 1, 2005

GenVec expands testing of AdPEDF for AMD

Feb. 24, 2005

Enrollment targets met in two phase II studies of squalamine for AMD

Feb. 17, 2005

Phase III data on the effects of diquafosol ophthalmic solution in patients with dry eye

Feb. 15, 2005

Novartis inlicenses rebamipide for dry eye

Feb. 9, 2005

Phase III confirmatory study of Photrex planned

Feb. 4, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...